In patients with type 2 diabetes who are asymptomatic for coronary heart disease, the presence of silent myocardial ischemia (SMI) and microalbuminuria (MA) at baseline may predict future coronary events, according to a report published in the July 3rd issue of the Journal of the American College of Cardiology.
Coronary heart disease is the number one cause of death in patients with type 2 diabetes. In this population, heart disease often presents without warning as myocardial infarction, heart failure, or even sudden death. Therefore, to allow therapeutic intervention, tests are needed that can predict which patients are at increased risk for coronary events.
SMI and MA have previously been identified as risk factors for cardiac-related mortality, but their predictive value in asymptomatic patients with type 2 diabetes has been unclear.
e-Med Tools
קצר קולע וממוקד
e-Med סמינרים
אי-מד תחקירים
Medscape Tools
Journal Club
מרכזי מידע ושירות
Facebook
מידע למפרסם
מאגר תרופות
מאגר אנשי המקצוע
אינדקס שימושי
חדשות משה"ב
eMed HealthClub
מחקרים קליניים
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!